Uncategorized

Nigeria Meets 70% COVID-19 Vaccination Target

Muhammad Sal

Nigeria successfully met its ambitious target of fully vaccinating 70 per cent of its population against the COVID-19 pandemic. Dr Bassey Okposen, Director of Disease Control and Immunization in the National Primary Health Care Development Agency (NPHCDA), disclosed this in an interview with News Agency of Nigeria (NAN), on Wednesday in Abuja.

NAN reports that Nigeria had a target of fully vaccinating 70 per cent of its eligible population by December 2022.

”The 70 per cent coverage with COVID-19 vaccines in all countries is a global imperative. In Nigeria, 70 per cent of eligible persons in Nigeria are fully vaccinated against COVID-19,” he said.

Okposen said that 80 per cent of eligible persons in the country were at least partially vaccinated against COVID-19 and 17.5 million fully vaccinated persons in Nigeria have received additional COVID-19 vaccines as booster doses.

According to him, as of Oct. 1, 132,212,099 vaccine doses have been administered in the country and six states have achieved 100 per cent of the target population vaccinated in the country. These states are Nasarawa, Jigawa, Osun, Kaduna, Kano and Adamawa,” he said.

He said that the milestone marks a crucial step in the country’s efforts to combat the ongoing pandemic and safeguard the health and well-being of its citizens.

“With an unwavering commitment to public health, Nigeria’s vaccination campaign has surpassed expectations, demonstrating the nation’s determination to control the spread of the virus and protect its population from the devastating impacts of COVID-19,” he said.
He noted that vaccinating 70 per cent of a country’s population against COVID-19 means that a significant portion of the population has received the required doses of a COVID-19 vaccine.

He further stated that by vaccinating 70 per cent of the population against COVID-19, a country greatly reduces the risk of widespread transmission, severe illness, and death caused by the virus. (NAN)

Leave a Reply

Your email address will not be published. Required fields are marked *